NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 82 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $30,000 | -37.5% | 46,999 | 0.0% | 0.01% | -28.6% |
| Q2 2022 | $48,000 | -45.5% | 46,999 | 0.0% | 0.01% | -41.7% |
| Q1 2022 | $88,000 | -61.2% | 46,999 | 0.0% | 0.01% | -58.6% |
| Q4 2021 | $227,000 | -33.2% | 46,999 | 0.0% | 0.03% | -39.6% |
| Q3 2021 | $340,000 | -21.7% | 46,999 | 0.0% | 0.05% | -25.0% |
| Q2 2021 | $434,000 | -25.0% | 46,999 | 0.0% | 0.06% | -32.6% |
| Q1 2021 | $579,000 | -56.3% | 46,999 | -50.0% | 0.10% | -17.4% |
| Q4 2020 | $1,326,000 | – | 93,998 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,225,000 | $15,080,000 | 2.22% |
| EcoR1 Capital, LLC | 3,122,704 | $38,440,000 | 1.70% |
| Redmile Group, LLC | 4,117,569 | $50,687,000 | 0.71% |
| HighVista Strategies LLC | 71,235 | $877,000 | 0.65% |
| Boxer Capital, LLC | 1,501,058 | $18,478,000 | 0.63% |
| Baker Brothers Advisors | 3,821,740 | $47,046,000 | 0.20% |
| Sio Capital Management, LLC | 38,312 | $472,000 | 0.10% |
| Highland Private Wealth Management | 46,999 | $579,000 | 0.10% |
| Point72 Asset Management, L.P. | 1,308,600 | $16,109,000 | 0.08% |
| Granahan Investment Management | 200,518 | $2,468,000 | 0.05% |